Print

Print


>    Subject: Re: I'm back
>    From: dpatel <[log in to unmask]>
>    Date: Thu, 12 Jul 2001 12:32:04 -0400

Dear Jacob,

Sorry that you did not receive a response. Amgen is something that I am
keeping an eye on myself. Most of the info I have found is from another
board. I am posting a link below to help you. The board is MGH- Neurology
forum. http://neuro-mancer.mgh.harvard.edu/ubb/Forum71/HTML/004848.html. If
you do a search using the term 'Amgen' pn this board you will find many
other related topics. If I can assist further, do please write back.
I hope this helps you in some way.

Dabu

----- Original Message -----
From: "Jacob M. Drollinger" <[log in to unmask]>
To: <[log in to unmask]>
Sent: Monday, July 09, 2001 3:58 PM
Subject: I'm back


> Dear friends,
>
> For some of you who were around two+ years ago, I will re-introduce
myself.
> For others who are relatively new to the list, mine is a new name.
> About 12 1/2 years ago, I attemped suicide by CO poisoning. I ended up
with
> bi-lateral lesions to both internal and external GP. The resulting
disability
> was similar to P.D. in that I exhibited some of the classic symptoms:
> rigidity, bradykinesia, dystonia, balance problems, and speech
impairments.
> However, the one thing I lack is tremor.
> I came back to the list to discuss recent developments in treating
> neurological disorders in general, and Parkinson's to be more specific. I
am
> especially interested in the clinical trials being done on P.D. patients
with
> the neuroimmunophilin ligands compound manufactured by Amgen.
> Is anyone on the list taking part in the trials, and if so, what, if any,
> positive results have you seen so far? Has anyone heard anything on phase
II?
>
> Jacob M. Drollinger Jr. 30 years old/diagnosed 12 years ago.

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn